These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4445987)

  • 1. Excercise-induced fibrinolytic activity and its effect on the degradation of fibrinogen, fibrin and fibrin-like precipitates.
    Gurewich V; Lipinska I; Lipinski B
    Thromb Res; 1974 Nov; 5(5):647-56. PubMed ID: 4445987
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH; Crowe MF
    J Clin Invest; 1975 Jun; 55(6):1190-4. PubMed ID: 1133167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise.
    Rosing DR; Brakman P; Redwood DR; Goldstein RE; Beiser GD; Astrup T; Epstein SE
    Circ Res; 1970 Aug; 27(2):171-84. PubMed ID: 5455624
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolysis at rest and after exercise in hepatic cirrhosis.
    Das PC; Cash JD
    Br J Haematol; 1969 Nov; 17(5):431-43. PubMed ID: 5346820
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative immunochemical determination of degradation products of fibrinogen and-or fibrin with high voltage electrophoresis.
    Niléhn JE
    Scand J Haematol Suppl; 1971; 13():215-7. PubMed ID: 5290683
    [No Abstract]   [Full Text] [Related]  

  • 7. The phylogeny of baboon fibrin-fibrinolysin.
    Hampton JW; McKee P
    Acta Zool Pathol Antverp; 1969 May; 48():59-62. PubMed ID: 4271524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of physical activity on fibrinolytic processes in healthy subjects].
    Ciko Z
    Vojnosanit Pregl; 1972 Nov; 29(11):494-7. PubMed ID: 4657449
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of crosslinked and noncrosslinked fibrin from the major classes of vertebrates.
    Schwartz ML; Pizzo SV; Sullivan JB; Hill RL; McKee PA
    Thromb Diath Haemorrh; 1973 May; 29(2):313-38. PubMed ID: 4762256
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the content of fibrinogen and its high-molecular derivatives as affected by the physical training of ischemic heart disease patients].
    Dudaev VA; Diukov IV; Borodkin VV
    Ter Arkh; 1986; 58(12):62-7. PubMed ID: 3824217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen of relatively high solubility, III. Residual clottable material in plasma deprived of the majority of fibrinogen.
    Jilg W; Hörmann H
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1316-24. PubMed ID: 4461634
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.
    Lipinska I; Lipinski B; Gurewich V; Hoffmann KD
    Am J Clin Pathol; 1976 Dec; 66(6):958-66. PubMed ID: 998569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of fibrin breakdown products and the interpretation of their appearance in the circulation.
    Gallimore MJ; Tyler HM; Shaw JT
    J Clin Pathol; 1972 Mar; 25(3):185-90. PubMed ID: 4622995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophoretic studies on fibrinogen subunits and factor-XIII+-stabilized fibrin, from normal and cobalt-treated rabbits].
    Krantz S; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):295-302. PubMed ID: 4130627
    [No Abstract]   [Full Text] [Related]  

  • 15. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
    Gormsen J; Feddersen C
    Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods of examining fibrinolysis in plasma.
    Gaffney PJ; Brasher M
    Nature; 1973 Aug; 244(5415):361-2. PubMed ID: 4583508
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinogenolysis and fibrinolysis with strenuous exercise.
    Ferguson EW; Barr CF; Bernier LL
    J Appl Physiol Respir Environ Exerc Physiol; 1979 Dec; 47(6):1157-61. PubMed ID: 536284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of ancrod as a defibrinating agent.
    Gaffney PJ; Brasher M
    Nature; 1974 Sep; 251(5470):53-4. PubMed ID: 4414691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.